Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Warsaw
Clinical trial register · Poland

Clinical Trials in Warsaw, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Poland and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 2705 matching records held by the registry are in this view. Synced 28 Oct 2026, 03:18 UTC
2705
Studies in scope
all four open statuses
1389
Recruiting now
open to new participants
512
Lead sponsors
across recruiting studies
Top sites
Warsaw 38 Krakow 24 Poznan 18 Wroclaw 16 Bydgoszcz 15
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
AstraZeneca95 Merck Sharp & Dohme LLC86 Medical University of Warsaw66 Hoffmann-La Roche61 Janssen Research & Development, LLC44 Clear sponsor filter
Site location
Warsaw38 Krakow24 Poznan18 Wroclaw16 Bydgoszcz15
All 34 locations
Target enrolment
to

Trials with a site in Warsaw

38 of 2705 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Poland
Start
Recruiting
AbbVie
Phase 2/3
490
Poznan, Krakow, Warsaw, Gdansk, Sosnowiec
2025-12-10
Recruiting
AbbVie
Phase 2
180
Poznan, Lublin, Warsaw
2025-11-25
Recruiting
AbbVie
Phase 3
120
Warsaw, Bialystok
2025-07-28
Recruiting
AbbVie
Phase 1/2
325
Poznan, Lublin, Warsaw
2025-07-23
Recruiting
AbbVie
Phase 2
180
Bydgoszcz, Krakow, Warsaw, Elblag, Olsztyn
2025-06-20
Active, closed
AbbVie
Phase 3
573
Poznan, Bydgoszcz, Krakow, Wroclaw, Warsaw, Chojnice, Bytom, Szczecin
2025-06-17
Recruiting
AbbVie
Phase 2
120
Bydgoszcz, Pruszków, Warsaw, Bialystok, Elblag
2025-04-11
Recruiting
AbbVie
Phase 3
420
Poznan, Bydgoszcz, Krakow, Wroclaw, Warsaw
2025-02-13
Active, closed
AbbVie
Phase 2
150
Skórzewo, Warsaw
2025-01-20
Recruiting
AbbVie
Phase 2
488
Bydgoszcz, Katowice, Krakow, Lublin, Poznan, Warsaw
2024-10-07
Recruiting
AbbVie
Phase 2
590
Bydgoszcz, Torun, Krakow, Warsaw, Sopot, Tychy, Kielce
2024-09-04
Active, closed
AbbVie
Phase 3
699
Poznan, Torun, Krakow, Wroclaw, Warsaw, Bialystok, Katowice
2024-08-19
Active, closed
AbbVie
Phase 3
111
Torun, Warsaw
2024-08-08
Recruiting
AbbVie
Phase 3
40
Cracow, Lublin, Warsaw, Sosnowiec, Lodz
2024-07-08
Active, closed
AbbVie
Phase 3
1,400
Bydgoszcz, Krakow, Warsaw, Katowice, Lodz
2024-06-27
Active, closed
AbbVie
Phase 3
614
Osielsko, Krakow, Warsaw, Bialystok, Katowice, Szczecin
2023-12-19
Recruiting
AbbVie
Phase 3
110
Torun, Warsaw
2023-12-11
Active, closed
AbbVie
Phase 3
289
Krakow, Warsaw
2023-11-15
Active, closed
AbbVie
Phase 3
122
Torun, Warsaw
2023-11-06
Recruiting
AbbVie
Phase 3
1,500
Osielsko, Torun, Krakow, Wroclaw, Warsaw, Bialystok, Katowice, Elblag
2023-10-11
Active, closed
AbbVie
Phase 3
1,014
Poznan, Bydgoszcz, Warsaw, Olsztyn
2023-07-25
By invitation
AbbVie
Phase 3
650
Poznan, Bydgoszcz, Krakow, Lublin, Warsaw, Wroclaw
2023-06-05
Recruiting
AbbVie
Phase 3
450
Poznan, Bydgoszcz, Krakow, Lublin, Warsaw, Wroclaw
2023-05-01
Recruiting
AbbVie
Phase 3
768
Poznan, Warsaw, Rzeszów, Olsztyn, Lodz
2022-03-25
Active, closed
AbbVie
Phase 1
520
Poznan, Warsaw, Przemyśl, Olsztyn
2021-10-13
Active, closed
AbbVie
Phase 3
132
Warsaw, Rzeszów, Gdansk, Lodz
2021-07-24
Active, closed
AbbVie
Phase 3
527
Torun, Krakow, Warsaw
2020-09-30
Active, closed
AbbVie
Phase 3
531
Bydgoszcz, Lublin, Warsaw, Gdansk, Katowice, Lodz
2020-09-10
Active, closed
AbbVie
Phase 3
330
Piła, Poznan, Krakow, Lublin, Warsaw, Gdansk, Katowice, Lodz
2020-08-31
Active, closed
An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial
NCT03844048Chronic Lymphocytic Leukemia, Acute Myeloid Leukemia, Multiple Myeloma, Non-Hodgkin's Lymphoma
DrugsVenclexta·Venetoclax
AbbVie
Phase 3
165
Krakow, Warsaw, Chorzów
2019-09-06
Active, closed
AbbVie
Phase 3
964
Bydgoszcz, Torun, Krakow, Grodzisk Mazowiecki, Warsaw, Bialystok, Elblag, Olsztyn
2019-03-25
Active, closed
AbbVie
Phase 1
364
Krakow, Warsaw, Lodz
2019-02-21
Active, closed
AbbVie
Phase 2
270
Poznan, Warsaw, Przemyśl, Szczecin, Lodz
2018-10-10
Active, closed
AbbVie
Phase 3
1,242
Bydgoszcz, Torun, Krakow, Wroclaw, Warsaw, Sopot, Katowice, Tychy
2018-08-28
Active, closed
AbbVie
Phase 3
1,336
Poznan, Torun, Wroclaw, Lublin, Warsaw, Rzeszów, Chojnice, Tychy
2018-04-09
Active, closed
AbbVie
Phase 3
747
Krakow, Wroclaw, Warsaw
2018-03-21
Active, closed
AbbVie
Phase 3
950
Torun, Warsaw, Sopot
2017-01-31
Active, closed
AbbVie
Phase 3
1,629
Torun, Cracow, Krakow, Wroclaw, Lublin, Grodzisk Mazowiecki, Warsaw, Bialystok
2015-12-01
Rows per page Showing 1–38 of 38
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Polish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 29 October 2026. https://priyalifescience.com/clinical-trials-poland/city/warsaw

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Poland and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 2,705 studies in total at the last sync on 28 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 38 of those studies with a site in Warsaw that also match the filters currently applied.

How many clinical trials are recruiting in Warsaw?

14 of the 38 studies on this page are recruiting new participants as of the 28 Oct 2026, 03:18 UTC sync. A further 0 have not yet opened recruitment, 23 are active but closed to new participants, and 1 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Warsaw), 38 studies
PhaseStudiesRecruitingShare
Phase 327771.1%
Phase 27518.4%
Phase 1205.3%
Phase 1/2112.6%
Phase 2/3112.6%

Most active sponsors

Lead sponsors with the most studies (Warsaw)
Lead sponsorStudiesRecruiting
AbbVie3814
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.